99 related articles for article (PubMed ID: 8686314)
1. Cost effectiveness of cholesterol-lowering drugs: a review of the evidence.
Thorvik E; Aursnes I; Kristiansen IS; Waaler HT
Wien Klin Wochenschr; 1996; 108(8):234-43. PubMed ID: 8686314
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
Martens LL; Rutten FF; Kuijpens JL; Winter J
Ned Tijdschr Geneeskd; 1991 Apr; 135(15):655-9. PubMed ID: 1903849
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of lipid-lowering treatment according to lipid level.
Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA
Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451
[TBL] [Abstract][Full Text] [Related]
5. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness of pharmacologic treatments for the reduction of blood lipids].
Plans Rubió P; Rovira Forns J
Med Clin (Barc); 1995 Sep; 105(9):327-33. PubMed ID: 7500685
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Tonkin AM; Eckermann S; White H; Friedlander D; Glasziou P; Magnus P; Kirby A; Mulray S; Denton M; Sallaberger M; Hunt D; Simes J;
Am Heart J; 2006 Jun; 151(6):1305-12. PubMed ID: 16781242
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain.
Rubió PP
Public Health; 1997 Jan; 111(1):33-40. PubMed ID: 9033222
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of prescription recommendations for cholesterol-lowering drugs: a survey of a representative sample of American cardiologists.
Gaspoz JM; Kennedy JW; Orav EJ; Goldman L
J Am Coll Cardiol; 1996 Apr; 27(5):1232-7. PubMed ID: 8609348
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of statins in coronary heart disease.
Franco OH; Peeters A; Looman CW; Bonneux L
J Epidemiol Community Health; 2005 Nov; 59(11):927-33. PubMed ID: 16234419
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.
Prosser LA; Stinnett AA; Goldman PA; Williams LW; Hunink MG; Goldman L; Weinstein MC
Ann Intern Med; 2000 May; 132(10):769-79. PubMed ID: 10819699
[TBL] [Abstract][Full Text] [Related]
15. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.
Tsevat J; Kuntz KM; Orav EJ; Weinstein MC; Sacks FM; Goldman L
Am Heart J; 2001 May; 141(5):727-34. PubMed ID: 11320359
[TBL] [Abstract][Full Text] [Related]
17. Cost of lipid lowering in patients with coronary artery disease by case method learning.
Kiessling A; Zethraeus N; Henriksson P
Int J Technol Assess Health Care; 2005; 21(2):180-6. PubMed ID: 15921057
[TBL] [Abstract][Full Text] [Related]
18. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
Ess SM; Szucs TD
Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and cost among lipid-lowering agents in patients with primary hypercholesterolemia.
Lacour A; Derderian F; LeLorier J
Can J Cardiol; 1998 Mar; 14(3):355-61. PubMed ID: 9551029
[TBL] [Abstract][Full Text] [Related]
20. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
Simoons ML; Casparie AF
Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
